Court Orders Illumina to Pay Syntrix $96M for Patent Infringement | GenomeWeb

NEW YORK (GenomeWeb News) – A federal court jury has ordered Illumina to pay $96 million in damages to Syntrix Biosystems in a patent infringement case.

According to the jury, Illumina infringed Syntrix's US Patent No. 6,951,682 through the sale of its BeadChip array products. The damage award is based on a royalty rate of 6 percent for BeadChip products that were sold by Illumina between 2005 and 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.